Regional Media

mainly cloudy 76°. Wind: SSE 5 mph.
Loading advertisement…
Trending: At least 12 people shot at an Ohio street festival and suspects remain at large, police say
HomeNewsNationalHealth ( Page 91)

Health

Subscribe to the Health News Feed.
SHARE NOW
by

Drug developer Generate Biomedicines raises $400 million in US IPO

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering comes as the IPO market remains volatile, with swings in high-growth technology stocks ...
by

Congo and US agree to $1.2 billion health partnership

KINSHASA, Congo (AP) - The United States and Congo signed a $1.2 billion health partnership Thursday, the two countries' governments said in a joint statement. The Department of State said it will provide up to $900 million over the next five years to support the ...
by

Sunway Healthcare launches $736 million IPO, Malaysia’s largest in nine years

By Danial Azhar and Yantoultra Ngui KUALA LUMPUR/SINGAPORE, Feb 27 (Reuters) - Sunway Healthcare Holdings launched on Friday its initial public offering that is expected to raise at least 2.86 billion ringgit ($735.98 million) in what would be Malaysia's largest listing in almost a decade. The ...
by

Mom of a preemie crochets colorful yarn octopi for tiny tots at Detroit hospital NICU

DETROIT (AP) - Joelle Haley went into labor on Christmas Day, giving birth to a son two days later - premature at 24 weeks. In the soothing darkness of a Detroit hospital room a little something was missing for the newborn Kieran and his ...
by

Democratic Republic of Congo and US agree $1.2 billion strategic health partnership

Feb 26 - Democratic Republic of Congo and the United States have agreed a $1.2 billion strategic health partnership, the two governments said in a joint statement on Thursday. The partnership covers the period of 2026-2031, the statement said. It includes $900 million in targeted ...
by

US FDA approves first line use of Boehringer Ingelheim’s lung cancer drug

Feb 26 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Boehringer Ingelheim's zongertinib as a first-line treatment for a rare form of non-small cell lung cancer, making it the second drug cleared under the agency's new speedy review program. Zongertinib, to be ...
Loading advertisement…
by

Eli Lilly reports additional data on weight-loss pill from diabetes trial

Feb 26 (Reuters) - Eli Lilly on Thursday released new data from a head-to-head trial of its experimental weight-loss pill, orforglipron, and rival Novo Nordisk's oral semaglutide in diabetes patients, giving a more detailed picture of the side effects. * About ...
by

Universal Health Services misses quarterly profit estimates on lower medical care demand

Feb 25 (Reuters) - Hospital operator Universal Health Services on Wednesday missed estimates for quarterly results, hurt by lower-than-expected admissions. Shares of the company were down 1.3% in after-market trading. As subsidies under Affordable Care Act or Obamacare plans expire this year, hospitals are set to ...
by

Zambia pushed back on U.S. health funding deal to protect interests, government says

By Jennifer Rigby, Chris Mfula and Olivia Kumwenda-Mtambo LONDON, Feb 25 (Reuters) - Zambia has pushed back on part of a deal worth more than $1 billion in global health aid from the United States because it does not align with the country's interests, the ...
by

China’s Jiuyuan Genetic seeks approval for Wegovy biosimilar

SHANGHAI, Feb 26 (Reuters) - Jiuyuan Genetic Biopharmaceutical has applied for approval to sell its experimental biosimilar version of Novo Nordisk's blockbuster weight-loss drug Wegovy in China, the Chinese drugmaker said Wednesday. The move comes ahead of a key patent expiry in the world's ...
by

Sarepta Therapeutics CEO Ingram to retire by year end

Feb 25 (Reuters) - Sarepta Therapeutics CEO Douglas Ingram has decided to step down by the end of 2026 or upon the appointment of his replacement, the company said in a regulatory filing. The company said it has commenced a search for his replacement. ...
by

UK’s Hikma shares plunge to over three-year low as forecast disappoints

Feb 26 (Reuters) - Britain's Hikma Pharmaceuticals forecast slower annual revenue growth and profit that missed market expectations on Thursday as margins at its injectables business continue to be squeezed, sending its shares down 17% to a more than three-year low. Hikma also withdrew its ...
First Previous878889909192939495Next Last